The independent source for health policy research, polling, and news.
7,941-7,960 of 113,007 results
A panel of expert advisers unanimously recommended Friday that the agency broaden its approval of Leqembi, a treatment for Alzheimer's disease manufactured by Eisai and Biogen. Other pharmaceutical news reports on penalties for drug price hikes, Medicare negotiations, and more.
Attorneys may present the deal to a federal appeals court Tuesday that would preserve the ACA's preventive care mandate while the case challenging the measure plays out in the courts.
Today's early morning highlights from the major news organizations.
Editorial writers discuss long covid, masking, medical debt, and more.
Each week, KFF Health News finds longer stories for you to enjoy. This week we have stories on Ukraine, dysentery, avian flu, step counting, and the pardon of Kathleen Folbigg, who was recently cleared of killing her four children.
State and federal health leaders pushed Medicaid recipients to re-up their enrollment or risk losing coverage, Minnesota Public Radio reports. In other news, the new food stamp requirements in the debt ceiling law area said to be testing states and the Department of Agriculture.
HHS' new national plan includes measures to prevent sexually transmitted infections, increase research, and improve coordination among federal agencies. But Roll Call reports that judicial and legislative obstacles could hinder the effort.
News outlets report on the FDA panel's meeting, set for today. The FDA doesn't have to follow any recommendation made concerning Leqembi, but typically does. In other news, the FTC investigation into pharmacy benefit managers broadend to include Emisar Pharma Services.
Medical residents and fellows at Massachusetts' largest health system have voted to unionize by joining the Committee of Interns and Residents, creating one of the largest unions of this kind. Among other health industry news, Amazon's One Medical expands into Connecticut.
The monoclonal antibody treatment, called Beyfortus by developers Sanofi and AstraZeneca, is aimed at preventing respiratory syncytial virus in infants and vulnerable toddlers. Separately, a new analysis shows a high shortfall of mpox vaccine uptake among Black Americans.
President Joe Biden, speaking against a rash of state laws targeting rights of the LGBTQ+ community, also said such laws come from "prejudiced people" and are "totally, thoroughly unjustified, ugly” and “wrong.” Louisiana's governor said he intends to veto a package of anti-LGBTQ+ bills.
ABC News reports that despite backing a strict abortion ban in North Dakota, Gov. Doug Burgum said he would not support a national ban if elected to the White House. Politico covers a political back-and-forth surrounding House Speaker Kevin McCarthy between abortion centrists and conservatives.
Dr. Ashish Jha is thus departing next week. President Joe Biden thanked Jha for helping save millions of American lives. Meanwhile, the search for a unique strain of covid in Ohio, fatigue hitting long covid sufferers, and more are also in the news.
Philadelphia got the worst of it Thursday, with its air quality hitting a hazardous 361 at one point, significantly worse than the levels in New York and Washington. (A number below 50 is considered "good.") Meanwhile, experts warn that this event increases the risk of catching covid.
The Centers for Medicare & Medicaid Services announced that it will test a new primary care model in eight states for a 10-year period. The experiment will weigh the concept of paying Medicare and Medicaid providers for the value of services, rather than the volume.
In a 7-2 decision in the case of Health and Hospital Corporation of Marion County v. Talevski, the Supreme Court justices preserved the civil rights of people who depend on initiatives funded in part by the federal government — such as Medicaid and programs that provide services for nutrition and disabilities — to sue states over enforcement violations.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Editorial writers tackle these public health issues and more.
Opinion writers delve into drug shortages, popular drugs, pharmacy benefit managers, and more.
© 2026 KFF